XM does not provide services to residents of the United States of America.
B
B

BureauVeritas

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

Bodycote, Croda, Spectris

EUROPE RESEARCH ROUNDUP- Bodycote, Croda, Spectris July 31 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bodycote, Croda and Spectris, on Wednesday. HIGHLIGHTS * Bodycote Plc BOY.L : HSBC cuts target price to 940p from 950p * Bucher Industries AG BUCN.S : Berenberg cuts target price to CHF 464 from CHF 470 * Croda CRDA.L : HSBC cuts target price to 4400p from 4800p * Spectris Plc SXS.L : JP Morgan raises target price to 2,950p fr
A
A
A
B
B
B
C
C
C
C
D
D
E
E
G
G
H
I
L
S
S
S
A
D
F
I
I
P

Jet2, Natwest Group, Unilever

EUROPE RESEARCH ROUNDUP-Jet2, Natwest Group, Unilever July 29 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Jet2, Natwest Group and Unilever, on Monday. HIGHLIGHTS * BAE Systems BAES.L : Citigroup raises to buy from neutral * Drax Group Plc DRX.L : Morgan Stanley raises target price to 670p from 650p * Jet2 Plc JET2.L : HSBC raises target price to 2020p from 1980p * Natwest Group Plc NWG.L : Berenberg raises target price to 415p
A
A
A
A
A
B
B
B
B
B
B
B
C
C
C
D
E
G
I
K
L
R
R
S
U
V
A
A
A
A
B
D
E
S

Top of the Street: Nestle, Anglo American, Bureau Veritas

BUZZ-Top of the Street: Nestle, Anglo American, Bureau Veritas A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Deutsche Bank downgrades Nestle NESN.S to "hold" from "buy", saying the world's biggest packaged food company went "a cut too far" as it trimmed its sales growth outlook on Thursday ** UBS raises British miner Anglo American AAL.L to "buy" from "neutral" as it sees better risk/reward ratio after the stock fell enough following BHP's BHP.AX offer
B
B
N
S
A
M

Bureau Veritas shines thanks to organic growth beat

BUZZ-Bureau Veritas shines thanks to organic growth beat ** Shares in Bureau Veritas BVI.PA rise 5.8% after the company delivered H1 results ahead of the consensus ** "We believe the market will respond well to Bureau Veritas' strong organic growth beat and healthy margin progression, with some likely re-rating from current levels", J.P. Morgan ana
B
B
S

Greencore, UCB, Unilever

EUROPE RESEARCH ROUNDUP-Greencore, UCB, Unilever July 26 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Greencore, UCB, and Unilever, on Friday. HIGHLIGHTS * Greencore GNC.L : HSBC raises target price to 190p from 160p * Lonza Group AG LONN.S : JP Morgan raises target price to CHF 645 from CHF 600 * Sartorius Stedim Biotech STDM.PA : HSBC cuts target price to EUR 310 from EUR 360 * UCB SA UCB.BR : TD Cowen raises target price to E
A
A
A
B
B
B
B
B
C
D
D
E
G
G
G
L
N
N
P
R
S
U
A
A
A
A
A
A
B
D
J

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.